These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12957214)

  • 1. Putative anxiety-linked effects of the nitric oxide synthase inhibitor L-NAME in three murine exploratory behavior models.
    Czech DA; Jacobson EB; LeSueur-Reed KT; Kazel MR
    Pharmacol Biochem Behav; 2003 Jul; 75(4):741-8. PubMed ID: 12957214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nitric oxide synthesis inhibitor L-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test.
    Vale AL; Green S; Montgomery AM; Shafi S
    J Psychopharmacol; 1998; 12(3):268-72. PubMed ID: 10958253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the nitric oxide synthase inhibitors on the behaviour of small-platform-stressed mice in the plus-maze test.
    Pokk P; Väli M
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):241-7. PubMed ID: 11817500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of nitric oxide in anxiety following transient cerebral ischemia in mice.
    Nakashima MN; Ajiki K; Nakashima K; Takahashi M
    J Pharmacol Sci; 2003 Jan; 91(1):47-52. PubMed ID: 12686730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential role of NOS inhibitors on stress-induced anxiety and neuroendocrine alterations in the rat.
    Joung HY; Jung EY; Kim K; Lee MS; Her S; Shim I
    Behav Brain Res; 2012 Dec; 235(2):176-81. PubMed ID: 22884925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze.
    Volke V; Kõks S; Vasar E; Bourin M; Bradwejn J; Männistö PT
    Neuroreport; 1995 Jul; 6(10):1413-6. PubMed ID: 7488737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of nitric oxide agents in the dorsal hippocampus of mice on anxiogenic-like effect induced by histamine.
    Piri M; Nasehi M; Asgariyan M; Zarrindast MR
    Pharmacol Biochem Behav; 2012 Sep; 102(3):391-9. PubMed ID: 22687724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise training with concomitant nitric oxide synthase inhibition improved anxiogenic behavior, spatial cognition, and BDNF/P70S6 kinase activation in 20-month-old rats.
    Salehpour M; Khodagholi F; Zeinaddini Meymand A; Nourshahi M; Ashabi G
    Appl Physiol Nutr Metab; 2018 Jan; 43(1):45-53. PubMed ID: 28854337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
    Wiley JL; Cristello AF; Balster RL
    Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ventral hippocampal nitric oxide/cGMP pathway in anxiety-related behaviors in rats submitted to the elevated T-maze.
    Calixto AV; Duarte FS; Duzzioni M; Nascimento Häckl LP; Faria MS; De Lima TC
    Behav Brain Res; 2010 Feb; 207(1):112-7. PubMed ID: 19800925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of functional relationship between mouse hippocampal cholinergic and nitrergic systems in anxiogenic-like behavior.
    Zarrindast MR; Piri M; Bananej M; Shahab Z; Zahmatkesh M
    Behav Pharmacol; 2013 Jun; 24(3):229-36. PubMed ID: 23625379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nitric oxide synthase inhibitor, N(G)-nitro-L-arginine methyl ester, attenuates lipoprivic feeding in mice.
    Czech DA; Kazel MR; Harris J
    Physiol Behav; 2003 Oct; 80(1):75-9. PubMed ID: 14568310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze: implications for the involvement of P2Y1 receptor-mediated nitric oxide production.
    Kittner H; Franke H; Fischer W; Schultheis N; Krügel U; Illes P
    Neuropsychopharmacology; 2003 Mar; 28(3):435-44. PubMed ID: 12629523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive interaction between scopolamine and nitric oxide agents on immobility in the forced swim test but not exploratory activity in the hole-board.
    Nasehi M; Mohammadi-Mahdiabadi-Hasani MH; Ebrahimi-Ghiri M; Zarrindast MR
    Psychopharmacology (Berl); 2019 Nov; 236(11):3353-3362. PubMed ID: 31175384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.
    Spolidório PC; Echeverry MB; Iyomasa M; Guimarães FS; Del Bel EA
    Psychopharmacology (Berl); 2007 Dec; 195(2):183-92. PubMed ID: 17661019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester.
    Devan BD; Pistell PJ; Daffin LW; Nelson CM; Duffy KB; Bowker JL; Bharati IS; Sierra-Mercado D; Spangler EL; Ingram DK
    Eur J Pharmacol; 2007 Jun; 563(1-3):134-40. PubMed ID: 17362916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test.
    Faria MS; Muscará MN; Moreno Júnior H; Teixeira SA; Dias HB; De Oliveira B; Graeff FG; De Nucci G
    Eur J Pharmacol; 1997 Mar; 323(1):37-43. PubMed ID: 9105874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats.
    Forestiero D; Manfrim CM; Guimarães FS; de Oliveira RM
    Psychopharmacology (Berl); 2006 Jan; 184(2):166-72. PubMed ID: 16362401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nitric oxide synthase inhibitors 7-NI, L-NAME, and L-NOARG in staircase test.
    Pokk P; Väli M
    Arch Med Res; 2002; 33(3):265-8. PubMed ID: 12031632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice.
    Ferraz-de-Paula V; Stankevicius D; Ribeiro A; Pinheiro ML; Rodrigues-Costa EC; Florio JC; Lapachinske SF; Moreau RL; Palermo-Neto J
    Braz J Med Biol Res; 2011 May; 44(5):428-37. PubMed ID: 21503414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.